| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2988294 | Journal of Vascular Surgery | 2015 | 5 Pages |
Abstract
SFA lesion complexity, as defined by TASC II severity, drives the cost of endovascular interventions but does not appear to disadvantage patency at 1Â year. Reimbursement agencies should consider incorporating disease severity into reimbursement algorithms for lower extremity endovascular interventions.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Karen L. MD, Brian W. MD, Jesse A. MD, Eva M. MD, Philip P. MD, Daniel B. MD, Benjamin J. BA, Richard J. MD,